HK1029393A1 - Prevention of sudden infant death - Google Patents

Prevention of sudden infant death

Info

Publication number
HK1029393A1
HK1029393A1 HK01100131A HK01100131A HK1029393A1 HK 1029393 A1 HK1029393 A1 HK 1029393A1 HK 01100131 A HK01100131 A HK 01100131A HK 01100131 A HK01100131 A HK 01100131A HK 1029393 A1 HK1029393 A1 HK 1029393A1
Authority
HK
Hong Kong
Prior art keywords
prevention
infant death
sudden infant
pylori
sids
Prior art date
Application number
HK01100131A
Other languages
English (en)
Inventor
Jan Hedner
Anders Pettersson
Original Assignee
Diabact Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diabact Ab filed Critical Diabact Ab
Publication of HK1029393A1 publication Critical patent/HK1029393A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/90—Breath testing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Alarm Systems (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK01100131A 1995-11-07 2001-01-05 Prevention of sudden infant death HK1029393A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9503937A SE9503937D0 (sv) 1995-11-07 1995-11-07 Förebyggande av plötslig spädbarnsdöd
PCT/SE1996/001428 WO1997017612A1 (en) 1995-11-07 1996-11-06 Prevention of sudden infant death

Publications (1)

Publication Number Publication Date
HK1029393A1 true HK1029393A1 (en) 2001-03-30

Family

ID=20400118

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01100131A HK1029393A1 (en) 1995-11-07 2001-01-05 Prevention of sudden infant death

Country Status (11)

Country Link
US (1) US6083756A (xx)
EP (2) EP1019726B1 (xx)
JP (1) JP3635303B2 (xx)
AT (2) ATE302024T1 (xx)
DE (2) DE69635091T2 (xx)
DK (2) DK1019726T3 (xx)
ES (2) ES2173326T3 (xx)
HK (1) HK1029393A1 (xx)
PT (1) PT1019726E (xx)
SE (1) SE9503937D0 (xx)
WO (1) WO1997017612A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ081099A0 (en) * 1999-06-07 1999-06-24 University Of Newcastle Research Associates Limited, The A method of determining potential susceptibility to development of alte and/or sids
DE10006432A1 (de) * 2000-02-14 2001-08-16 Ganzimmun Inst Fuer Ganzheitli Verfahren zum Nachweis von Helicobacter pylori in Stuhl- und Speichelproben
US7733233B2 (en) * 2006-10-24 2010-06-08 Kimberly-Clark Worldwide, Inc. Methods and systems for monitoring position and movement of human beings
CN103376317B (zh) * 2012-04-12 2015-11-18 徐超 不同疫苗适用性与经济性的现场判定方法
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5848975A (en) * 1996-07-01 1998-12-15 St. Vincent's Medical Center Of Richmond Breath test for helicobacter pylori

Also Published As

Publication number Publication date
EP1121938B1 (en) 2005-08-17
JP2000500859A (ja) 2000-01-25
DE69635091D1 (de) 2005-09-22
EP1121938A2 (en) 2001-08-08
US6083756A (en) 2000-07-04
WO1997017612A1 (en) 1997-05-15
ES2173326T3 (es) 2002-10-16
JP3635303B2 (ja) 2005-04-06
ES2249345T3 (es) 2006-04-01
DE69619283D1 (de) 2002-03-21
DE69635091T2 (de) 2006-06-29
EP1019726A1 (en) 2000-07-19
ATE302024T1 (de) 2005-09-15
EP1019726B1 (en) 2002-02-13
PT1019726E (pt) 2002-07-31
DK1019726T3 (da) 2002-05-27
EP1121938A3 (en) 2002-04-24
DK1121938T3 (da) 2005-12-12
SE9503937D0 (sv) 1995-11-07
DE69619283T2 (de) 2002-11-14
ATE213331T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
EG19451A (en) Disposable diaper having differentially stretchable ears with childproof fastening.
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
CA2122612A1 (en) Pharmaceutical products for curing tumourous diseases and process for preparing same
ZA895936B (en) Pharmaceutical compositions comprising selected lactobacillus strains
CA2341261A1 (en) Improved baby products and methods of manufacture
AU9164391A (en) Low birth weight infant pacifier
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
NO20061094L (no) Antistoff samt anvendelse derav til fremstilling av medikamenter til behandling av B-celle-lymfom
Black et al. Human volunteer studies with Campylobacter jejuni
EP0494405A3 (en) Use of thiazolidine-4-carboxylate derivatives and glutathione esters for the treatment of pulmonary diseases
EP1298203A3 (en) Diagnosis and treatment of autoimmune diseases
AU7405091A (en) Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
HK1029393A1 (en) Prevention of sudden infant death
USD312147S (en) Knee pad for babies, toddlers and small children
JPH01168903A (ja) つかいすておむつ
JPS55113721A (en) Immunity regulator
EP0247226A3 (en) Perch for infants and handicapped individuals
Tazi-Lakhsassi et al. Amoxycillin-clavulanic acid tolerance in children.).
Begue et al. Ceftazidime in severe paediatric infections. A review of the literature.
Prado H. influenzae carriers in pediatric health personnel: Efficacy of enoxacin for eradication of carrier state.
Todisco et al. Nosocomial infection due to Pseudomonas aeruginosa in an oculistic department.
Lacaille Administration of RU 41740, a prophylactic immunomodulator protecting against infection, during an episode of acute respiratory infection. Summarized results of 3 therapeutic trials.
Znaozhou Analysis of Mortality Rate of 3617 Burn Patients
Chalub et al. Tetanus following intramuscular injection E. P. Chalub, E. M. Villegas.
Boudignat et al. Comparative study of two dosage regimens of cefixime in the treatment of upper and lower respiratory tract infections.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20071106